Moderna Inc (NASDAQ: MRN) shares are surging above the $70 level for the first time since late May following sell-side commentary on its coronavirus vaccine program. The Moderna Analyst: Jefferies analyst Michael Yee initiated coverage of Moderna with a Buy rating and $90 price target. The Moderna Thesis: There is good probability the vaccine will work…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. Politico had some choice words for media members who praise New York Gov. Andrew Cuomo but "love to hate" Florida Gov. Ron DeSantis for reopening his state after coronavirus data suggests a sunny outlook — but a CNN analyst dismissed it as “snarky nonsense.”In Thursday night's coronavirus newsletter,…
U.S.|Grand Juror in Breonna Taylor Case Says Deliberations Were MisrepresentedThe Kentucky attorney general’s office said it would release the panel’s recordings after a grand juror contended in a court filing that its discussions were inaccurately characterized.Breonna Taylor's family and the lawyer Ben Crump, right, said the charges a Kentucky grand jury agreed upon in the…
(John Finney Photography/Moment/Getty Images) An abnormally bad season of weather may have had a significant impact on the death toll from both World War I and the 1918 Spanish flu pandemic, according to new research, with many more lives being lost due to torrential rain and plummeting temperatures. Through a detailed analysis of an ice…